The Bioinformatics & Biotechnology Shared Resource provides a broad range of chemistry, biomolecular, and bioinformatics services and expertise in support of Cancer Center research programs. It includes six sections: Bioinformatics, High-throughput DNA Sequencing and Genotyping, Macromolecular Synthesis, Functional Genomics, Clinical Applications Core Technology (CACT), and Proteomics. Bioinformatics provides investigators with access to high-performance computing resources, bioinformatics software, and all major public biomolecular databases. Highthroughput DNA Sequencing & Genotyping provides investigators with access to automated DNA sequence analysis, fragment size analysis, and SNP detection technologies. Macromolecular Synthesis provides synthetic peptides and synthetic oligonucleotides to Cancer Center investigators (CCSG support is not be requested for this section). Functional Genomics provides cDNA microarray services and analyses to Center investigators. The Clinical Applications Core Technology section provides oligonucleotide-based microarray analysis (Affymetrix, Inc.) for investigators. (Functional Genomics and the CACT laboratory activities will be combined in this application). Proteomics offers a range of protein chemistry capabilities including protein sequence analysis using Edman chemistry, protein identification using mass spectrometry, and protein interaction analysis using surface plasmon resonance technology. All sections are highly integrated and readily accessible using our Web-based on-line ordering and tracking system and a comprehensive relational database system housing all chemistry information. The projected total budget for this Shared Resource in year-25 of this grant is $4,089,971 of which 12% ($498,763) is requested from the CCSG; the remainder of the budget (88%, $3,591,208) will be provided by SJCRH institutional funds and by chargeback to individual investigators. Over 80% of the usage of this Shared Resource is by Cancer Center members for peer-reviewed projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA021765-25S1
Application #
6602679
Study Section
Project Start
2002-06-24
Project End
2007-02-28
Budget Start
Budget End
Support Year
25
Fiscal Year
2002
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Scott, Jessica M; Li, Nan; Liu, Qi et al. (2018) Association of Exercise With Mortality in Adult Survivors of Childhood Cancer. JAMA Oncol 4:1352-1358
Rong, Yongqi; Bansal, Parmil K; Wei, Peng et al. (2018) Glycosylation of Cblns attenuates their receptor binding. Brain Res 1694:129-139
Levine, Jennifer M; Whitton, John A; Ginsberg, Jill P et al. (2018) Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 124:1044-1052
Li, Jian-Feng; Dai, Yu-Ting; Lilljebjörn, Henrik et al. (2018) Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proc Natl Acad Sci U S A 115:E11711-E11720
Sharma, Akshay; Kang, Guolian; Sunkara, Anusha et al. (2018) Haploidentical Donor Transplantation Using a Novel Clofarabine-containing Conditioning Regimen for Very High-risk Hematologic Malignant Neoplasms. J Pediatr Hematol Oncol 40:e479-e485
Waszak, Sebastian M; Northcott, Paul A; Buchhalter, Ivo et al. (2018) Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol 19:785-798
Zheng, Wenting; O'Hear, Carol E; Alli, Rajshekhar et al. (2018) PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells. Leukemia 32:1157-1167
Heikamp, Emily B; Pui, Ching-Hon (2018) Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia. J Pediatr 203:14-24.e2
Sadighi, Zsila S; Curtis, Elizabeth; Zabrowksi, Jennifer et al. (2018) Neurologic impairments from pediatric low-grade glioma by tumor location and timing of diagnosis. Pediatr Blood Cancer 65:e27063
Wierdl, Monika; Tsurkan, Lyudmila; Chi, Liying et al. (2018) Targeting ALK in pediatric RMS does not induce antitumor activity in vivo. Cancer Chemother Pharmacol 82:251-263

Showing the most recent 10 out of 6764 publications